Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.22.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Loss for the period $ (17,215) $ (31,566)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets   2
Depreciation of property and equipment 45 15
In-process research and development   16,094
Change in fair value of milestone liability (10) 14
Interest expense   23
Amortization of deferred loan costs   74
Warrants issued for services 35 438
Stock option expense 2,283 4,248
Changes in operating assets and liabilities    
Prepaid expenses, deposits and other (998) (2,594)
Accounts payable and accrued liabilities 563 (640)
Related party payables (103) (279)
Net cash used in operating activities (15,400) (14,171)
Cash flows from investing activities    
Cash acquired on merger with Adgero   969
Purchase of equipment   (8)
Proceeds on sale of equipment   3
Net cash provided by investing activities   964
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 13,634 21,598
Warrants exercised for cash 74 4,399
Stock options exercised for cash   42
Proceeds from loan   500
Series A preferred cash dividend (6) (6)
Net cash provided by financing activities 13,702 26,533
(Decrease) increase in cash and cash equivalents (1,698) 13,326
Cash and cash equivalents – beginning of period 10,537 2,392
Cash and cash equivalents – end of period $ 8,839 $ 15,718